Aptose Biosciences Inc (TSX:APS)
C$ 0.54 -0.01 (-1.82%) Market Cap: 10.54 Mil Enterprise Value: 98,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Q4 2020 Aptose Biosciences Inc Earnings Call Transcript

Mar 23, 2021 / 09:00PM GMT
Release Date Price: C$69.6 (-5.69%)
Operator

Good afternoon. My name is Carmen, and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences conference call for the year-end and fourth quarter ended December 31, 2020.

(Operator Instructions)

As a reminder, this conference call may be recorded. I would like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, Carmen. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the year-end and fourth quarter ended December 31, 2020. I am Susan Pietropaolo, communications representative for Aptose Biosciences. Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; Mr. Gregory Chow, Executive Vice President and Chief Financial Officer; Dr. Jotin Marango, Senior Vice President and Chief Business Officer; and Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer.

Before we proceed, I would like to remind everyone that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot